Page 48 - 2021 Taiwan Food and Drug Administration Annual Report
P. 48

Section 5                                                         conference to share COVID-19
                                                                      pandemic control experience
    Deepened the Medical                                              with partner countries in the New
    Information Exchange                                              Southbound Policy.
    of the New Southbound
    Policy                                                                7KH $JHQF\  KHOG  DQ  RQOLQH  FRQIHUHQFH  
                                                                      “Sharing Experience on COVID-19 Pandemic
    Introduction of the Policy                                        &RQWURO´  RQ  -XQH              DQG  LQYLWHG 
                                                                      representatives from the countries in the New
        In conjunction with the “New                                  6RXWKERXQG  3ROLF\   7KDLODQG   0DOD\VLD   WKH 
    6 R X W K E R X Q G   3 R O L F \ ´   L V V X H G   E \   W K H   3KLOLSSLQHV   WKH  8QLWHG  6WDWHV   WKH  (XURSHDQ 
    President and the Executive Yuan and                              8QLRQ   -DSDQ   6RXWK  .RUHD   &KLOH   DQG  RWKHU 
    the New Southbound Medical and Public                             pharmaceutical regulatory authorities to
    Health Collaboration and Industrial Chain                         attend the meeting. The Agency shared the
    Development flagship project from the                             VXFFHVVIXO H[SHULHQFH RI WKH ³7DLZDQ 0RGHO ´ 
    0LQLVWU\ RI +HDOWK DQG :HOIDUH  WKH FRQFHSWV                      which included “Accelerated review and
    RI  PXWXDO  XQGHUVWDQGLQJ   UHVRXUFHV  VKDULQJ                    SURMHFW  DSSURYDO  IRU  SDQGHPLF  FRQWURO  GUXJV  
    and creation of business opportunities and                        PHGLFDO HTXLSPHQW  DQG LQVSHFWLRQ UHDJHQWV ´ 
    goals were realized in the medical and                            ³$FWLYH  LQYHQWRU\  RI  GUXJV   VWUHQJWKHQHG 
    KHDOWK  ILHOG   ZKLFK  FRQWLQXH  WR  H[SDQG  DQG                  QRWLILFDWLRQ  DQG  HYDOXDWLRQ  RI  VKRUWDJH  
    cultivate the pharmaceutical partnerships                         and prevention stockpiling and uneven
    between Taiwan and other countries in the                         GLVWULEXWLRQ´  DQG  ³,QFUHDVHG  SURGXFWLRQ  RI 
    New Southbound Policy. The experience                             SDQGHPLF  FRQWURO  DOFRKRO   ORZHU  WDULIIV  DQG 
    gained from our long-term commitment in                           H[SRUW  FRQWUROV ´  HWF   5HSUHVHQWDWLYHV  RI 
    establishing a management environment for                         participating countries were invited to share
    international pharmaceutical regulations and                      their experience and measures in pandemic
    the relevant industry advantages reinforced                       control.
    pharmaceutical collaboration with New
    6RXWKERXQG  FRXQWULHV   GHYHORSHG  WKHLU  WUXVW                   $FKLHYHPHQWV DQG %HQH¿WV
    ZLWK  WKH  SURGXFWV  PDGH  E\  7DLZDQ   DQG 
    improved our access to the international                          Platform for sharing experience
    markets to jointly share the regional                             on pandemic control
    resources and promote regional development.
                                                                          Constructing supply chains of medicines
    Implementation Strategy                                           and pandemic control materials is a major
                                                                      public health issue that the world faces
    Organized an online international                                 during the COVID-19 pandemic period.
                                                                      By organizing the international conference

46
   43   44   45   46   47   48   49   50   51   52   53